Recombinant activated factor seven in pediatric cardiac surgery-does thrombotic risk outweigh hemostatic benefit?
作者信息
Scott John P
机构信息
Department of Anesthesiology and Pediatrics, Sections of Pediatric Anesthesiology and Pediatric Critical Care, Medical College of Wisconsin, Milwaukee, WI, USA.
出版信息
Transl Pediatr. 2019 Dec;8(5):465-467. doi: 10.21037/tp.2019.10.04.
Abstract
摘要
相似文献
1
Recombinant activated factor seven in pediatric cardiac surgery-does thrombotic risk outweigh hemostatic benefit?重组活化因子七在小儿心脏手术中的应用——血栓形成风险是否超过止血益处？
Transl Pediatr. 2019 Dec;8(5):465-467. doi: 10.21037/tp.2019.10.04.
2
Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.重组凝血因子VIIa与小儿心脏手术患者血栓形成并发症增加有关。
Anesth Analg. 2017 May;124(5):1431-1436. doi: 10.1213/ANE.0000000000001947.
3
Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.重组七因子在小儿心脏外科学中的血栓风险：单中心经验。
Ann Thorac Surg. 2010 Feb;89(2):570-6. doi: 10.1016/j.athoracsur.2009.11.023.
4
A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.应用重组活化因子 VII 治疗小儿心脏手术结局的倾向评分匹配分析。
J Cardiothorac Vasc Anesth. 2019 May;33(5):1269-1275. doi: 10.1053/j.jvca.2018.12.016. Epub 2018 Dec 12.
5
Recombinant activated factor VII following pediatric cardiac surgery.小儿心脏手术后的重组活化凝血因子VII
J Intensive Care Med. 2009 Mar-Apr;24(2):116-21. doi: 10.1177/0885066608330208. Epub 2009 Feb 2.
6
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.重组活化因子 VII 在儿科心脏手术患者中标签外使用的回顾。
Anesth Analg. 2012 Aug;115(2):364-78. doi: 10.1213/ANE.0b013e31825aff10. Epub 2012 May 31.
7
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.应用重组活化因子 VII 控制体外循环下心内直视手术后难治性出血
J Cardiothorac Vasc Anesth. 2011 Dec;25(6):987-94. doi: 10.1053/j.jvca.2011.05.012. Epub 2011 Aug 11.
8
The role of recombinant factor VIIa in on-pump cardiac surgery: proceedings of the Canadian Consensus Conference.重组凝血因子VIIa在心脏搭桥手术中的作用：加拿大共识会议纪要
Can J Anaesth. 2007 Jul;54(7):573-82. doi: 10.1007/BF03022322.
9
A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.非常低剂量重组活化因子 VII 在心脏手术后难治性出血中的作用：一项观察性研究的经验教训。
J Thorac Cardiovasc Surg. 2018 Oct;156(4):1564-1573.e8. doi: 10.1016/j.jtcvs.2018.03.167. Epub 2018 Apr 18.
10
Efficacy and safety of activated recombinant factor VII in cardiac surgical patients.活化重组凝血因子VII在心脏手术患者中的疗效与安全性
Curr Opin Anaesthesiol. 2009 Feb;22(1):95-9. doi: 10.1097/ACO.0b013e32831a40a3.
本文引用的文献
1
Recombinant activated factor VII in neonatal cardiac surgery.重组活化因子 VII 在新生儿心脏手术中的应用。
Eur J Cardiothorac Surg. 2019 May 1;55(5):817-822. doi: 10.1093/ejcts/ezy483.
2
Relationship Between Transfusion of Blood Products and the Incidence of Thrombotic Complications in Neonates and Infants Undergoing Cardiac Surgery.心脏手术新生儿及婴幼儿输血与血栓并发症发生率的关系
J Cardiothorac Vasc Anesth. 2017 Dec;31(6):1943-1948. doi: 10.1053/j.jvca.2017.04.039. Epub 2017 Apr 27.
3
Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.重组凝血因子VIIa与小儿心脏手术患者血栓形成并发症增加有关。
Anesth Analg. 2017 May;124(5):1431-1436. doi: 10.1213/ANE.0000000000001947.
4
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.重组活化因子 VII 在儿科心脏手术患者中标签外使用的回顾。
Anesth Analg. 2012 Aug;115(2):364-78. doi: 10.1213/ANE.0b013e31825aff10. Epub 2012 May 31.
5
Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery.儿童心脏手术相关血栓形成的风险、临床特征和结局。
Circulation. 2011 Oct 4;124(14):1511-9. doi: 10.1161/CIRCULATIONAHA.110.006304. Epub 2011 Sep 12.
6
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.应用重组活化因子 VII 控制体外循环下心内直视手术后难治性出血
J Cardiothorac Vasc Anesth. 2011 Dec;25(6):987-94. doi: 10.1053/j.jvca.2011.05.012. Epub 2011 Aug 11.
7
Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study.标签外重组因子 VIIa 在儿童中的应用与血栓形成：一项多中心队列研究。
J Pediatr. 2011 May;158(5):820-825.e1. doi: 10.1016/j.jpeds.2010.10.038. Epub 2010 Dec 10.
8
Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.重组七因子在小儿心脏外科学中的血栓风险：单中心经验。
Ann Thorac Surg. 2010 Feb;89(2):570-6. doi: 10.1016/j.athoracsur.2009.11.023.
9
Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.体外膜肺氧合期间难治性出血时的激活重组因子 VII。
Pediatr Crit Care Med. 2010 Jan;11(1):98-102. doi: 10.1097/PCC.0b013e3181b0620b.
10
Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here?界定重组活化凝血因子VII在小儿心脏手术中的作用：我们从这里该何去何从？
Pediatr Crit Care Med. 2009 Sep;10(5):572-82. doi: 10.1097/PCC.0b013e3181a642d5.
Zotero 插件